Efficacy and safety of Tirofiban following intravenous thrombolysis: a systematic review and meta-analysis of randomized controlled trials

Abstract Background The risk of re-occlusion and inadequate reperfusion limits the efficacy of intravenous thrombolysis (IVT) within 4.5 h for acute ischemic stroke (AIS). Tirofiban, a glycoprotein IIb/IIIa inhibitor, has been studied as an adjunctive treatment for patients with acute coronary syndr...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Sher Bano, Faisal Wali Ahmed, Atif Saeed, Ammar Nawazish, Muhammad Haris, Ayesha Mansoor, Ayesha Ghazal Jamali, Riaz Ahmed, Shaumile Hasan Khan, Numan Akram, Zainab Salahuddin, Muhammad Umar, Iman Osman Abufatima
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2026-04-01
Serija:	BMC Neurology
Teme:	Tirofiban Glycoprotein IIb/IIIa inhibitor Stroke Thrombolysis
Online dostop:	https://doi.org/10.1186/s12883-026-04892-8
Oznake:	Označite Brez oznak, prvi označite!